Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Peer-reviewed studies show that high-risk users of Hello Heart experience significant reductions in blood pressure—up to a mean drop of ~16 mm Hg systolic among those with Stage II hypertension—and improved cholesterol and weight. The program has demonstrated cost savings for employers ($1,709 per user annually) and reduced inpatient days by nearly half. Engagement rates are high across age groups, including seniors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hello Heart.